ICP-MS, RISK ASSESSMENT AND IMPLEMENTATION ON A PHARMACEUTICAL LABORATORY

• At: AbuDhabi (United Arab Emirates) (2019)
• Type: Poster
• Poster code: POS-ASP-008
• By: DIAS, Clarisse (INFOSAUDE-LEF (ANF), Pharmacy Support Department- Pharmacy Compounding, Portugal)
• Co-author(s): Fátima Carvalho: Technical and Executive Director, INFOSAUDE-LEF (ANF), OEIRAS, Portugal
  Duarte Santos: ANF Board Director, ANF, National Association of Pharmacies, Lisbon, Portugal
  Tania Rito: Quality Assurance, INFOSAUDE-LEF (ANF), OEIRAS, Portugal
  Ana Brízio: Quality Control & Stability, INFOSAUDE-LEF (ANF), OEIRAS, Portugal
  Fábio Brito: Analytical Development & Validation, INFOSAUDE-LEF (ANF), OEIRAS, Portugal
  Paula Rato: Analytical Development & Validation, INFOSAUDE-LEF (ANF), OEIRAS, Portugal
  Rita Lopes: Analytical Development & Validation, INFOSAUDE-LEF (ANF), OEIRAS, Portugal
  
• Abstract:

  Background

  “Strengthen return on investment through operational efficiency and build a culture of continuous improvement focused on higher success rates”

  Elemental Impurities are metal element traces that can be present in a drug product and do not contribute for substance's therapeutic effect posing in risk for human health.

  According to LEF's

  ..

The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login